This webinar is part of a series for general practitioners on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions.
It will soon be 2 years since the first depot buprenorphine product (Buvidal®) was made available in Australia via a product familiarisation programme, 18 months since it was TGA approved, and a year since another depot buprenorphine product (Sublocade®) was PBS listed, for treatment of opioid dependence. In this seminar we look at challenges in the delivery of this treatment modality in a range of metropolitan and regional settings as a case study for the larger question of how to make addiction treatment more available to the people who need it, whoever and wherever they are.
It's a free week-long gathering for everyone who's committed to improving the lives and health of men and boys in Australia.
Men’s Health Connected is held online, so you can take part from the comfort of your home or workplace and choose the times and the sessions that work best for you.
This Heart Week, the Heart Foundation are bringing together international and local CVD experts for an engaging discussion on the latest evidence for CVD prevention in primary care, including an update on coronary artery calcium scoring. The event is held in partnership with Australian Primary Health Care Nurses Association (APNA) and the World Heart Federation.
This online workshop is dedicated to Health And Education Professionals working with children who have additional needs.
Our program attracts 5 Professional Development (PD) hours. This workshop will cover:
Milestones in bladder and bowel development
Withholding behaviour and cycles
Nutrition & Diet
Addressing Additional sensory & behavioural needs & More
Hear from a panel with expertise, and experience of living with, and caring for someone, with COVID-19. This presentation and panel discussion features the National COVID-19 Clinical Evidence Taskforce which brings together 32 peak health professional bodies from across Australia.
Each week, more than 250 Taskforce contributors work together to find new research and quickly incorporate that research into national, evidence-based guidelines for the clinical care of Australians with COVID-19.
A webinar for Aboriginal health care workers: start conversations around hep C, increase testing & treatment and help eliminate hep C.
At the end of this webinar, you'll be able to:
Describe what hep C is, how it affects the body and how it's transmitted
Describe contributing issues that drive hepatitis C in Aboriginal community
Use person centered language to address stigma and discrimination
Learning outcomes
After completing this activity, GPs will be able to:
• Conduct a multidimensional assessment of cancer pain.
• Actively co-ordinate the care of patients with cancer.
• Identify and address psychosocial and spiritual factors that influence cancer pain, distress and suffering.
• Develop a multimodal pain management plan for patients with cancer pain.
• Initiate and modify opioid analgesics to optimise the management of severe cancer pain
Note: The Cancer Pain Management Master Class is an accredited program run over two nights. For accreditation of RACGP/ACRRM points, both PART A and PART B need to be completed in full.
This webinar on 29 April is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants' questions.